Dong Z - Search Results

1

Potential regulatory role of epigenetic modifications in aging-related heart failure.

Lv L, Chen Q, Lu J, Zhao Q, Wang H, Li J, Yuan K, Dong Z. Lv L, et al. Among authors: dong z. Int J Cardiol. 2024 Apr 15;401:131858. doi: 10.1016/j.ijcard.2024.131858. Epub 2024 Feb 13. Int J Cardiol. 2024. PMID: 38360101 Review.

2

AS3MT Polymorphisms, Arsenic Metabolism, and the Hematological and Biochemical Values in APL Patients Treated with Arsenic Trioxide.

Lu J, Hu S, Wang W, Li J, Dong Z, Zhou J, Hai X. Lu J, et al. Among authors: dong z. Toxicol Sci. 2018 Nov 1;166(1):219-227. doi: 10.1093/toxsci/kfy210. Toxicol Sci. 2018. PMID: 30376134

3

Influence of AS3MT polymorphisms on arsenic metabolism and liver injury in APL patients treated with arsenic trioxide.

Lu J, Yu K, Fan S, Liu W, Dong Z, Li J, Wang X, Hai X, Zhou J. Lu J, et al. Among authors: dong z. Toxicol Appl Pharmacol. 2019 Sep 15;379:114687. doi: 10.1016/j.taap.2019.114687. Epub 2019 Jul 19. Toxicol Appl Pharmacol. 2019. PMID: 31330140

4

Sacubitril/valsartan protects against arsenic trioxide induced cardiotoxicity in vivo and in vitro.

Wu Z, Chen H, Lin L, Lu J, Zhao Q, Dong Z, Hai X. Wu Z, et al. Among authors: dong z. Toxicol Res (Camb). 2022 May 16;11(3):451-459. doi: 10.1093/toxres/tfac018. eCollection 2022 Jun. Toxicol Res (Camb). 2022. PMID: 35782642 Free PMC article.

5

SUMOylation of SIRT1 activating PGC-1α/PPARα pathway mediates the protective effect of LncRNA-MHRT in cardiac hypertrophy.

Liu MY, Yue LJ, Luo YC, Lu J, Wu GD, Sheng SQ, Shi YQ, Dong ZX. Liu MY, et al. Eur J Pharmacol. 2022 Sep 5;930:175155. doi: 10.1016/j.ejphar.2022.175155. Epub 2022 Jul 19. Eur J Pharmacol. 2022. PMID: 35863508

6

Small ubiquitin-related modifier (SUMO)ylation of SIRT1 mediates (-)-epicatechin inhibited- differentiation of cardiac fibroblasts into myofibroblasts.

Luo Y, Lu J, Wang Z, Wang L, Wu G, Guo Y, Dong Z. Luo Y, et al. Among authors: dong z. Pharm Biol. 2022 Dec;60(1):1762-1770. doi: 10.1080/13880209.2022.2101672. Pharm Biol. 2022. PMID: 36086802 Free PMC article.

7

Integration of proteomic and metabolomic characterization in atrial fibrillation-induced heart failure.

Zhang H, Wang L, Yin D, Zhou Q, Lv L, Dong Z, Shi Y. Zhang H, et al. Among authors: dong z. BMC Genomics. 2022 Dec 1;23(1):789. doi: 10.1186/s12864-022-09044-z. BMC Genomics. 2022. PMID: 36456901 Free PMC article.

8

Sonodynamic therapy reduces cardiomyocyte apoptosis through autophagy activated by reactive oxygen species in myocardial infarction.

Xu Y, Dong Z, Zhang R, Wang Z, Shi Y, Liu M, Yang J, Yang T, Zhang R, Wang T, Zhang J, Zhang Y, Xiang F, Han Y, Wu J, Miao Z, Chen Q, Li Q, Wang Z, Tian Y, Guo Y. Xu Y, et al. Among authors: dong z. Free Radic Biol Med. 2023 Feb 1;195:36-46. doi: 10.1016/j.freeradbiomed.2022.12.080. Epub 2022 Dec 15. Free Radic Biol Med. 2023. PMID: 36529292

9

HypERlnc attenuates angiotensin II-induced cardiomyocyte hypertrophy via promoting SIRT1 SUMOylation-mediated activation of PGC-1α/PPARα pathway in AC16 cells.

Yue L, Sheng S, Yuan M, Lu J, Li T, Shi Y, Dong Z. Yue L, et al. Among authors: dong z. Cell Biol Int. 2023 Jun;47(6):1068-1080. doi: 10.1002/cbin.12001. Epub 2023 Feb 5. Cell Biol Int. 2023. PMID: 36740224

10

Suramin inhibits phenotypic transformation of vascular smooth muscle cells and neointima hyperplasia by suppressing transforming growth factor beta receptor 1 /Smad2/3 pathway activation.

Xu Y, Ge L, Rui Y, Wang Y, Wang Z, Yang J, Shi Y, Dong Z, Zhang Y, Zhang R, Yang T, Lv L, Xiang F, Chen S, Song A, Li T, Liu M, Guo Y. Xu Y, et al. Among authors: dong z. Eur J Pharmacol. 2024 Apr 5;968:176422. doi: 10.1016/j.ejphar.2024.176422. Epub 2024 Feb 15. Eur J Pharmacol. 2024. PMID: 38365108

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,729 results

Search Page